Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981]

Corrigendum to “Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.” [EClinicalMedicine 37 (2021) 100981]

Bibliographic Details
Main Authors: Vinicius Fontanesi Blum, MD, MSc, Sérgio Cimerman, MD, PhD, James R Hunter, PhD, Paulo Tierno, MD, Acioly Lacerda, Alexandre Soeiro, MD, Florentino Cardoso, MD, Nancy Cristina Bellei, PhD, MD, Juliana Maricato, PhD, Nathalia Mantovani, PhD, Marcella Vassao, MSc, Danilo Dias, Juliana Galinskas, Luis Mário Ramos Janini, MD, PhD, Joanna Reis Santos-Oliveira, PhD, Alda Maria Da-Cruz, MD, PhD, Ricardo Sobhie Diaz, MD, PhD
Format: Article
Language:English
Published: Elsevier 2021-11-01
Series:EClinicalMedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537021004843

Similar Items

Similar Items